Search
Now showing items 1-10 of 362
Protective effects of Tacrolimus, a calcineurin inhibitor, in experimental periodontitis in rats
(Elsevier B.V., 2007-09-01)
Objective: Periodontitis is a well-appreciated example of leukocyte-mediated bone loss and inflammation with pathogenic features similar to those observed in other inflammatory diseases, such as arthritis. Since Tacrolimus, ...
Treatment with tacrolimus enhances alveolar bone formation and decreases osteoclast number in the maxillae: A histomorphometric and ultrastructural study in rats
(F Hernandez, 2008-10-01)
Recent studies have suggested that tacrolimus monotherapy is a beneficial therapeutic alternative for the normalization of cyclosporin- induced bone loss in animal models and humans. The mechanism accounting for this action ...
Protective effects of Tacrolimus, a calcineurin inhibitor, in experimental periodontitis in rats
(Elsevier B.V., 2007-09-01)
Objective: Periodontitis is a well-appreciated example of leukocyte-mediated bone loss and inflammation with pathogenic features similar to those observed in other inflammatory diseases, such as arthritis. Since Tacrolimus, ...
Treatment with tacrolimus enhances alveolar bone formation and decreases osteoclast number in the maxillae: A histomorphometric and ultrastructural study in rats
(2008-12-01)
Recent studies have suggested that tacrolimus monotherapy is a beneficial therapeutic alternative for the normalization of cyclosporin-induced bone loss in animal models and humans. The mechanism accounting for this action ...
Exposição de fibroblastos provenientes de pterígios recidivados e da cápsula de Tenon normal ao tacrolimus (FK-506)
(2007-03-01)
Purpose: To evaluate fibroblast proliferation activity of normal Tenon's capsule and of recurrent pterygia exposed in vitro to tacrolimus (FK506). Methods: A randomized prospective study was performed with 8 samples of ...
Switching stable kidney transplant recipients to a generic tacrolimus Is feasible and safe, but it must be monitored
(Hindawi Publishing Corp., 2017)
Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate ...
Switching stable kidney transplant recipients to a generic tacrolimus Is feasible and safe, but it must be monitored
(Hindawi Publishing Corp., 2017)
Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate ...
Biochemical evaluation of glycemic levels of long-term tacrolimus therapy in rats
(2007-12-31)
One of the more serious complications following transplantation is the development of post-transplantation diabetes mellitus (PTDM), which has a major impact on the quality of life, with effects ranging from the control ...
Biochemical evaluation of glycemic levels of long-term tacrolimus therapy in rats
(2007-12-31)
One of the more serious complications following transplantation is the development of post-transplantation diabetes mellitus (PTDM), which has a major impact on the quality of life, with effects ranging from the control ...